Health China
Biomarker Assay Development
Hilton San Diego Resort

San Diego, California


   The increasing importance of biomarkers in the drug discovery process
   calls for a comprehensive biomarker strategy that must include assay
   development and validation. CHI’s Second Annual Biomarker Assay
   Development meeting addresses ‘fit-for-purpose’ method development,
   spanning pre-clinical and clinical drug development, as well as
   diagnostics. The meeting will provide an overview of novel assay
   platforms for genomic and proteomic analysis, as well as multiplexed
   assays, flow cytometry, and biomarker assays in oncology. The
   Biomarker Assay Development meeting will also address the pros and
   cons of developing the assay in-house vs. adopting off-the-shelf
   solutions/kits vs. outsourcing.

Schedule of Presentations:

Monday, January 25, 2010
Tuesday, January 26, 2010
Wednesday, January 27, 2010
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.